SCHEMBL21881883

SCHEMBL21881883

CP(C)(=O)c1ccc(-c2c3ccc4ccccc4c3nc3c2ccc2ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 4/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
MAOA P21397 1/20 0.36
HPRT1 P00492 1/20 0.34
POLR1A O95602 3/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP2A6 P11509 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ESR1 P03372 2/20 0.32
MEN1 O00255 2/20 0.32
RAB9A P51151 2/20 0.32
KMT2A Q03164 2/20 0.32
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18892986 0.98 MAPT (0.38) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL18892962 0.92 MAOA (0.42) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL18892982 0.90 MAOA (0.41) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL18892980 0.89 MAPT (0.37) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL15004342 0.88 CYP1A2 (0.38) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL18904710 0.87 HSD17B1 (0.34) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL18893031 0.86 MAPT (0.37) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL21882053 0.86 MAPT (0.37) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL15004452 0.85 ESR1 (0.37) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1
SCHEMBL14993845 0.85 CYP1A1 (0.37) MAPTL3MBTL1CYP1A2CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 MAPT 4555/4885L3MBTL1 812/4885CYP1A2 148/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 MAPT 4555/4885L3MBTL1 812/4885CYP1A2 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.